| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |